These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1520246)

  • 1. Frequency-dependent action of antiarrhythmic drugs: the useful concept of periodical ligand binding.
    Weirich J
    Basic Res Cardiol; 1992; 87(3):205-14. PubMed ID: 1520246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy.
    Weirich J; Antoni H
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):998-1009. PubMed ID: 1694924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs.
    Weirich J; Antoni H
    Basic Res Cardiol; 1998; 93 Suppl 1():125-32. PubMed ID: 9833140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects of frequency-dependent effect of class 1 anti-arrhythmia drugs. A critical analysis of useful subclassification].
    Weirich J; Antoni H
    Z Kardiol; 1991 Mar; 80(3):177-86. PubMed ID: 2058249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium channel states control binding and unbinding behaviour of antiarrhythmic drugs in cardiac myocytes from the guinea pig.
    Koumi S; Sato R; Katori R; Hisatome I; Nagasawa K; Hayakawa H
    Cardiovasc Res; 1992 Dec; 26(12):1199-205. PubMed ID: 1337728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential analysis of frequency-dependent effects of antiarrhythmic drugs: importance of the saturation behavior of frequency-dependent sodium-channel blockade.
    Weirich J; Hohnloser S; Antoni H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S8-16. PubMed ID: 1279314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of Vmax block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle.
    Kohlhardt M; Seifert C
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):235-44. PubMed ID: 2414674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling frequency- and voltage-dependent effects of a class I antiarrhythmic drug (nicainoprol) on Vmax of the cardiac action potential from guinea-pig papillary muscle.
    Weirich J; Antoni H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):456-64. PubMed ID: 2586635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
    Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
    Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Block of sodium currents by antiarrhythmic agents: analysis of the electrophysiologic effects of propafenone in heart muscle.
    Kohlhardt M
    Am J Cardiol; 1984 Nov; 54(9):13D-19D. PubMed ID: 6093494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
    Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and action of antiarrhythmic drugs.
    Borchard U; Berger F; Hafner D
    Eur Heart J; 1989 Sep; 10 Suppl E():31-40. PubMed ID: 2478366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
    Gómez R; Caballero R; Barana A; Amorós I; De Palm SH; Matamoros M; Núñez M; Pérez-Hernández M; Iriepa I; Tamargo J; Delpón E
    Cardiovasc Res; 2014 Nov; 104(2):337-46. PubMed ID: 25205296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of cardiac Na+ channels by a charged class I antiarrhythmic agent, bisaramil: possible interaction of the drug with a pre-open closed state.
    Sunami A; Hiraoka M
    Eur J Pharmacol; 1996 Sep; 312(2):245-55. PubMed ID: 8894603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo.
    Todt H; Zojer N; Raberger G
    Br J Pharmacol; 1993 Sep; 110(1):145-50. PubMed ID: 8220875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.